FDA approved cardura medicine sustained release form of doxazosin, to be marketed as Cardura® XL.It is an alpha-1 adrenergic receptor blocker which inhibits the binding of norepinephrine to alpha receptors in the autonomic nervous system. The primary effect of this blockage is relaxed vascular cardura medicine muscle tone.

98%Metabolism HepaticHalf life 22 cardura medicine ?Therapeutic considerationsPregnancy cat. ?Legal status ? Prescription cardura medicine oralDoxazosin mesylate, a quinazoline compound cardura medicine by Pfizer under the brand cardura medicine Cardura® and Carduran® , is an alpha blocker used to treat high blood pressure and benign prostatic hyperplasia.On February 22, 2005, the US FDA approved a sustained release form of doxazosin, to be marketed as Cardura® XL.It is an alpha-1 adrenergic receptor blocker which inhibits the binding of norepinephrine to alpha receptors cardura medicine the autonomic nervous system. cardura medicine primary effect of this blockage is relaxed vascular smooth muscle tone (vasodilation), which decreases peripheral vascular resistance, leading to decreased blood pressure. DoxazosinFrom Wikipedia, the free encyclopedia(Redirected from Cardura)Jump to: navigation, searchDoxazosinSystematic (IUPAC) name[4-(4-amino-6,7-dimethoxy- quinazolin-2-yl) piperazin-1-yl]- cardura medicine deca-6,8,10-trien-4-yl) methanoneIdentifiersCAS.

from Cardura)Jump to: navigation, searchDoxazosinSystematic (IUPAC) name[4-(4-amino-6,7-dimethoxy.